Banque Cantonale Vaudoise’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $880K | Hold |
16,000
| – | – | 0.04% | 378 |
|
|
2025
Q1 | $1.13M | Buy |
+16,000
| New | +$1.13M | 0.05% | 335 |
|
|
2024
Q3 | $1.13M | Sell |
16,000
-350
| -2% | -$24.6K | 0.05% | 300 |
|
|
2024
Q2 | $1.35M | Hold |
16,350
| – | – | 0.05% | 301 |
|
|
2024
Q1 | $1.43M | Sell |
16,350
-414
| -2% | -$36.2K | 0.06% | 302 |
|
|
2023
Q4 | $1.62M | Sell |
16,764
-2,870
| -15% | -$277K | 0.07% | 265 |
|
|
2023
Q3 | $1.74M | Sell |
19,634
-536
| -3% | -$47.4K | 0.09% | 190 |
|
|
2023
Q2 | $1.75M | Sell |
20,170
-50
| -0.2% | -$4.33K | 0.08% | 212 |
|
|
2023
Q1 | $1.97M | Sell |
20,220
-3,800
| -16% | -$369K | 0.1% | 204 |
|
|
2022
Q4 | $2.49M | Buy |
24,020
+3,742
| +18% | +$387K | 0.13% | 157 |
|
|
2022
Q3 | $1.72M | Buy |
20,278
+522
| +3% | +$44.3K | 0.1% | 199 |
|
|
2022
Q2 | $1.64M | Sell |
19,756
-700
| -3% | -$58K | 0.08% | 225 |
|
|
2022
Q1 | $1.58M | Hold |
20,456
| – | – | 0.07% | 282 |
|
|
2021
Q4 | $1.81M | Sell |
20,456
-962
| -4% | -$85K | 0.07% | 266 |
|
|
2021
Q3 | $1.66M | Buy |
21,418
+15,500
| +262% | +$1.2M | 0.07% | 272 |
|
|
2021
Q2 | $494K | Sell |
5,918
-2,415
| -29% | -$202K | 0.02% | 593 |
|
|
2021
Q1 | $628K | Sell |
8,333
-5,778
| -41% | -$435K | 0.03% | 479 |
|
|
2020
Q4 | $1.24M | Buy |
14,111
+1,414
| +11% | +$124K | 0.07% | 251 |
|
|
2020
Q3 | $964K | Sell |
12,697
-2,064
| -14% | -$157K | 0.06% | 265 |
|
|
2020
Q2 | $1.82M | Buy |
14,761
+7,557
| +105% | +$932K | 0.13% | 156 |
|
|
2020
Q1 | $608K | Sell |
7,204
-416
| -5% | -$35.1K | 0.05% | 318 |
|
|
2019
Q4 | $644K | Buy |
+7,620
| New | +$644K | 0.04% | 386 |
|